BioLineRx gets US patent covering use of BL-8040 in immunotherapy
Israel-based clinical-stage biopharmaceutical firm BioLineRx has announced that an Issue of Notification has been received from the US Patent…
ByThank you for subscribing to Pharmaceutical Technology